MedTrace Logo

Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia

NCT00633659 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2013-08-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of Hemospan infusion on vascular reactivity, regional perfusion and oxygenation of ischemic tissue in patients with chronic critical lower limb ischemia.

Conditions

  • Vascular Disease
  • Critical Lower Limb Ischemia

Interventions

DRUG

Hemospan (MP4OX)

250 mL of Hemospan (MP4OX)

DRUG

Voluven (HES 130/0.4)

250 mL of Voluven (HES 130/0.4) solution

Sponsors & Collaborators

  • Sangart

    lead INDUSTRY

Principal Investigators

  • Pär Olofsson, MD, PhD · Karolinska University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-06-30
Completion
2008-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00633659 on ClinicalTrials.gov